The FDAs concern is twofold: Safety: Some substances are linked to toxicity, cardiac complications, or other serious adverse events
Nerve Block & Infiltration Anesthesia: Provides targeted pain relief for acute pain management and regional nerve blocks
Note that the FDA has approved many peptide drugs over the years more generally including insulin
CJC-1295 / Ipamorelin peptide injections may be incorporated into wellness programs designed to support natural growth hormone signaling, recovery, and vitality
Throughout the 0-32 week treatment period, adverse outcomes and the occurrence of anti-cagrillintide antibodies were assessed in addition to any changes in systolic and diastolic blood pressure, pulse rate, plasma high-sensitivity C-reactive protein, aldosterone, and the activity of renin